Anal Genital Warts

Anal genital wart (also known as venereal genital wart, anal genital warts and condylomata acuminata) are external symptoms of infection by the human papilloma virus (HPV). hpv is a family of viruses with more than 100 strains, the symptoms of which include anal genital warts, genital anal warts, common warts on hands, and plantar warts on feet.

The American Social Health Association reports the number of Americans with at least one form of sexually transmitted hpv at more than 20 million, with approximately 5.5 million new cases every year, making it the most prevalent and rapidly spreading sexually transmitted disease in the country.

Anal Genital Warts symptoms

It is important to note that many individuals infected with HPV do not have outward signs, and may not know they are infected. Results from a study conducted by the National Institute for Allergies and Infectious Diseases indicate that as many as 50% of women infected with HPV do not show outward symptoms and are unaware that they are infected. This is a considerable factor in the rapid spread of the virus.

When anal genital warts do appear, they can range in size from very tiny bumps to large cauliflower-shaped growths. Anal warts which occur outside the rectum are called perianal; those which occur inside the rectum are called intra-anal and affect the lower inch or two of the rectum.

While pain is generally not associated with anal genital warts, occasionally minor bleeding will result from anal sex or bowel movements. Left untreated, anal warts may result in bowel obstruction.

Genital anal warts are highly contagious and transmission most often results from direct contact, usually sexual in nature, with an infected individual. It is estimated that two thirds of people having sexual contact with infected individuals will develop genital or anal warts within three months.

While common genital warts that appear on the hands and feet are forms of HPV, they are not the same strain of HPV virus that causes anal warts. Contact with an individual intermittently affected by common warts will not result in venereal genital wart transmission, unless the individual also carries a venereal wart strain of the HPV virus.

Detection and Diagnosis of Anal Warts

Because HPV is not a systemic infection, that is, it exists only in the skin cells; there is no blood test to detect it. Medical personnel will typically identify an anal wart infection by visually inspecting the suspected area, sometimes with a magnifying glass, to verify the presence of warts. Sometimes vinegar is applied to the skin to cause infected tissues to turn white, and render them more easily perceptible.

Anal Wart Treatment

Genital anal warts are the outward symptoms of a viral infection which may persist indefinitely in the tissues around the affected area. Treatments are intended to remove the warts so as to reduce the possibility of spreading the virus to others, as well as to eliminate any physical or psychological discomfort associated with anal warts. Removal of warts, however, is not necessarily a cure. As long as the virus is present, anal warts may recur and require additional treatment.

Various treatments are currently recommended by physicians to remove anal warts. Anal wart treatment s include, but are not limited to, topical chemical solutions, topical anti-viral solutions, immunotherapy, cryotherapy (using liquid nitrogen), surgical removal, and electrosurgery.

Coping with anal warts

Most people are very upset to discover they have contracted a sexually transmitted form of HPV. Gathering as much information about the virus as possible and seeking out support groups can be very helpful in coming to terms with the situation and moving forward to a happy, healthy life.

Protection against anal warts

Abstaining from sex with individuals infected with warts or HPV is the best way to avoid contracting the virus or passing it on to a sexual partner. Obviously this is not always practical advice. Since the infection is not always apparent, and because committed partners may decide the risk of passing HPV is outweighed by the benefits of initiating a sexual relationship, use of a condom or dental dam (female sexual barrier device) is recommended for any and all sexual activity. This precaution does not ensure safety from infection, as the virus may be present in skin surrounding the genitals, and therefore not covered by the barrier.

Note: This information is not intended as a substitute for medical advice. If you suspect you have venereal warts or anal warts, consult a physician.

gabriele valenti - About the Author:

Eric Johnson writes about HPV and Warts Treatments and Genital Warts and warts Treatments

Source:  http://www.articlesbase.com/diseases-and-conditions-articles/anal-genital-warts-187754.html

Vaccinate to Protect Against HPV

Several issues about the vaccine remain to be addressed. It will be important to confirm that the strong safety profile remains intact as more individuals receive the vaccine. It remains to be determined how long the high level of type-specific protection is maintained, as this issue will have implications for whether and when booster injections might be advisable and will also contribute to the cost-effectiveness of the vaccine.

A substantial degree of cross-protection could increase the potential impact of the vaccine by further reducing the incidence of serious genital HPV infections and by reducing the number of abnormal Pap tests and the cost of their follow-up. On the other hand, protection against heterologous HPV types is likely to wane more quickly than that against the HPV types specifically targeted by the vaccine, which could also have implications for boosting.

Another unanswered question is whether vaccination might alter the natural history of prevalent HPV infection by reducing the incidence of persistent infection or cytological abnormalities. The large vaccine trials may have a sufficient number of prevalent infections attributable to the HPV types in the vaccine to address this question.

If such a “therapeutic effect” were seen, it could provide an added rationale to vaccinate sexually active women who might have prevalent infection with one of the types in the vaccine. The most likely explanation for such an effect would be that the vaccine had reduced the efficiency of transmission of an early infection from one genital site to other genital sites, presumably via specific antibodies in the genital tract.

It is also possible that the vaccine could have direct therapeutic effects against established lesions. However, this possibility seems less likely, as persistent infection is usually attributed to the presence of the viral genome in long-lived basal epithelial cells, which do not express L1. The experimental evidence also does not support this possibility.

A key question will be whom to vaccinate. In the United States, the main national advisory committee will be the Advisory Committee on Immunization Practices at the Centers for Disease Control and Prevention. Until there are data that show the vaccine is protective in men, it would seem most logical to focus public health efforts primarily on vaccinating women.

If the principal activity of the vaccine is the prevention of incident HPV infection, the greatest reduction in the number of infections would likely result from immunizing girls or women before they become sexually active. In the United States, this consideration would imply that pre- or young adolescent girls would be prime candidates for the vaccine.

Of course, older girls and women with no prior sexual exposure should also achieve maximum benefit from the vaccine, which implies that “catch-up” vaccination for these groups should be seriously considered. Giving the vaccine to women who have had some prior sexual activity could also reduce their number of infections, although their degree of benefit from the vaccine would probably be inversely related to their degree of prior sexual activity.

Most pharmacology efforts now focus on developing a vaccine to inoculate the population in order to stop the HPV virus from infecting the system. This is ideal for the pharmaceutical companies as it would of course reap a monetary windfall of epic proportions for the drug companies, but not useful at all for those already affected with warts. Most doctors use cauterization or freezing as a first option to cure genital warts.

Unfortunately, success achieved with this method is often temporary and the warts soon reappear. HPVCurative is a new, highly effective and potent way to cure genital warts. It is valued for its role in the realm of genital warts cures, and has provided total clearance of the infection time after time.

It contains certified organic medicinal plant extracts and antiviral essential oils, which have demonstrated the ability to act as an HPV cure in laboratory tests. Users of HPVCurative experience rapid elimination of genital warts without scarring or recurrence. The treatment is painless and provides superb results when compare to other HPV cures.

It eliminates genital warts and restores skin tissue to the state it was in prior to the infection. Since the treatment can effectively remove genital warts and wart-like substances on the genitals, acid or surgical HPV cures may soon become a thing of the past. To learn more, please go to http://www.bcured.net. 

bcured - About the Author:

staff of Nature Power Company, which is a network company dedicated to promoting customers' websites and developing softwares. You can go to the following websites to learn more about our natural organic products. http://www.bcured.net  http://www.naturespharma.org

Source:  http://www.articlesbase.com/medicine-articles/vaccinate-to-protect-hpv-1615650.html

HPV Infection and Disease

Of the 10 million cases of cancer that develop annually throughout the world, more than 15% are estimated to be attributable to infectious agents. Infection by human papilloma viruses (HPVs) accounts for approximately 30% of these cancers, with hepatitis B and C viruses and Helicobacter pylori together accounting for another 60% of cancers with an infectious etiology.

HPVs infect the stratified squamous epithelia of skin and mucous membranes, where they cause benign lesions, some of which have the potential to progress to invasive cancer. HPVs are small, nonenveloped viruses whose approximately 8-kb circular genome encodes 2 structural proteins, L1 and L2, that form the viral capsid, plus several nonstructural proteins that are important for the virus life cycle but are not incorporated into virions.

To establish infection, microtrauma or erosion of the overlying epithelial layers is thought to enable HPVs to infect cells of the basal epithelial layer, where the stem cells and other long-lived cells are found. To establish infection, the virus must infect basal epithelial cells that are long lived or have stem cell-like properties. Microtrauma to the suprabasal epidermal cells probably enables the virus to infect the cell within the basal layer.

The viral genome maintains itself as an episome in basal cells, where the viral genes are poorly expressed. Viral replication takes place in suprabasal layers and is tied to the epidermal differentiation process. The presence of the virus causes morphological abnormalities in the epithelium, including papillomatosis, parakeratosis, and koilocytosis. Progeny virus is released in desquamated ces.

HPV infections tend to last months or years because the viral genome successfully parasitizes these cells and because the virus evades the immune system by limiting most viral gene expression and viral replication to suprabasal cell layers. Most infections are self-limited, presumably because the host eventually mounts a successful immune response.

The benign lesions induced by HPVs include nongenital and anogenital skin warts, oral and laryngeal papillomas, and anogenital mucosal condylomata. Progression from a benign cervical lesion to invasive cervical cancer. Infection by oncogenic HPV types, especially HPV16, may directly cause a benign condylomatous lesion, low-grade dysplasia, or sometimes even an early high-grade lesion.

Carcinoma in situ rarely occurs until several years after infection. It results from the combined effects of HPV genes, particularly those encoding E6 and E7, which are the 2 viral oncoproteins that are preferentially retained and expressed in cervical cancers; integration of the viral DNA into the host DNA; and a series of genetic and epigenetic changes in cellular genes. HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesn.

Anogenital infections are almost always transmitted sexually. Long-term infection by a subset of HPVs can lead to malignant anogenital tumors, including cancers of the anus, penis, vulva, vagina, and cervix. A proportion of oral cancer is also attributable to HPV. While HPV infection has been associated on limited occasions with esophageal cancer and skin cancer, a frequent causal link, although plausible, remains more tenuous.

Most doctors use cauterization or freezing as a first option to cure genital warts. Unfortunately, success achieved with this method is often temporary and the warts soon reappear. For genital warts, cures may involve having to surgically excise or burn them off. After surgical intervention or chemical acids are used, one can expect a scar in that area.

Warts occurring on the body, face, feet, hands or genitals can be successfully eliminated with AntiWarts-Rx. This product is made from strictly certified organic antiviral plant material and concentrated with naturally occurring monoterpene ketones which have tremendous antiviral effects against the wart virus, HPV, as demonstrated in published scientific studies.

As some go their entire life without ever having a wart, while others seem prone to the infection, it is commonly believed occurrences of warts are associated with a lower immunity against HPV. As a result, ImmunoDrops for Warts is a powerful organic dietary supplement developed by NaturesPharma exclusively to combat HPV and strengthen immune parameters for those afflicted with warts.

Our anti-warts treatments are characterized by very strong and real pharmacological activities which unequivocally qualifies them as “ethical drugs”. The antiviral properties of these treatments are undisputed and basic common sense must be considered when using any treatment, natural or synthetic. To learn more, please go to http://www.naturespharma.org. 

bcured - About the Author:

staff of Nature Power Company, which is a network company dedicated to promoting customers' websites and developing softwares. You can go to the following websites to learn more about our natural organic products. http://www.bcured.net http://www.naturespharma.org

Source:  http://www.articlesbase.com/medicine-articles/hpv-infection-and-disease-1592008.html

Prevention of HPV

The vaccine currently marketed in the United States prevents infection by human papilloma virus (HPV) types 6, 11, 16, and 18. Vaccination against HPV types 16 and 18 is most effective in preventing infections from these viruses in females who have not previously been infected with these types.

It is most effective when given before the onset of sexual activity. The impact of this vaccine on the incidence of cervical cancer will not be observable for years. Its effectiveness will depend on the duration of immunity and will be optimized by achieving maximum coverage of the target population.

Most investigators agree that routine immunization in females should begin at approximately age 12 years. Since the vaccine has been widely available only for a few years, catch-up vaccinations are currently recommended in previously unvaccinated females beginning at age 13 years and ranging to an upper limit of age 18-26 years.

Educating women, particularly those who are socially and economically disadvantaged, about behaviors that enhance sexual risk reduction has a proven benefit in reducing the incidence of STDs. Reducing the incidence of STDs potentially could decrease HPV transmission and, consequently, the incidence of cervical carcinoma.

Condom use may reduce the transmission of HPV to uninfected sex partners, but it does not eliminate the risk. Furthermore, caution patients that treatment does not eliminate the possibility of HPV transmission because latent virus still may be present in tissues adjacent to treated areas.

The risk of perinatal human papilloma virus (HPV) transmission to the oropharyngeal mucosa of the neonate is low for mothers with latent infections or genital warts. The time between rupture of the amnion and delivery may be a critical factor in predicting transmission.

Infants with HPV-positive nasopharyngeal aspirates in the immediate postpartum period are considered contaminated rather than infected with HPV because the virus generally clears from the neonate over several months after birth. Cesarean delivery for the prevention of vertical HPV transmission to the newborn is not indicated. However, in rare cases, cesarean delivery may be indicated if the pelvic outlet is obstructed by large genital warts.

Approximately two thirds of patients with nongenital cutaneous warts experience a spontaneous regression within 2 years; however, some new warts may appear. Genital warts may spontaneously regress, remain unchanged, or increase in size. Treatment of these lesions does not affect the development of cervical cancer.

Most doctors use cauterization or freezing as a first option to cure genital warts. Unfortunately, success achieved with this method is often temporary and the warts soon reappear. For genital warts, cures may involve having to surgically excise or burn them off. After surgical intervention or chemical acids are used, one can expect a scar in that area.

Surgical intervention as a HPV cure attempts not only to cut out the virus but also to stimulate tissue inflammation. The theory is that the body will then develop an antibody response to prevent viral recurrence. However, this method to cure genital warts often fails as doctors are unable to remove the virus in its entirety, since it commonly lodges itself deep in the dermal layers of the skin.

Among all the types of genital warts cures, genital surgery subjects the patient to a highly invasive procedure. This method can be most unpleasant and ineffective, and can also create genital scarring. An alternative antiviral treatment is now available which represents a very promising solution to the growing epidemic of genital warts.

HPVCurative is a new, highly effective and potent way to cure genital warts. It is valued for its role in the realm of genital warts cures, and has provided total clearance of the infection time after time. Results are guaranteed. It contains certified organic medicinal plant extracts and antiviral essential oils, which have demonstrated the ability to act as an HPV cure in laboratory tests.

Users of HPVCurative experience rapid elimination of genital warts without scarring or recurrence. The treatment is painless and provides superb results when compare to other HPV cures. It eliminates genital warts and restores skin tissue to the state it was in prior to the infection. Since the treatment can effectively remove genital warts and wart-like substances on the genitals, acid or surgical HPV cures may soon become a thing of the past.

Alkaloids exhibiting a broad spectrum of antiviral activity have been identified in a select few herbal extracts, which have been blended into all of our HPV cures. These antiviral alkaloids can penetrate into human tissue, and are known to be highly effective in genital warts cures. To learn more, please go to http://www.bcured.net. 

bcured - About the Author:

staff of Nature Power Company, which is a network company dedicated to promoting customers' websites and developing softwares. You can go to the following websites to learn more about our natural organic products. http://www.bcured.net   http://www.naturespharma.org

Source:  http://www.articlesbase.com/medicine-articles/prevention-of-hpv-1403975.html

Treatments For Hpv Infection In Men

Some of the 30 or so types of HPV associated with genital cancers can lead to cancer of the anus or penis in men. Both of these cancer types are rare, especially in men with a healthy immune system. Other types of HPV virus rarely cause cancer in men, but they do cause genital warts. At a given point in time, about 1% of sexually active men in the U.S. will have genital warts.

The risk of anal cancer is about 17 times higher in sexually active gay and bisexual men than in men who have sex only with women. If a man's long-term sexual partner has HPV, chances are good HPV transmission has already occurred and he also has it. Men who have HIV are also at higher risk of getting this cancer.

The HPV types associated with cervical cancer usually do not cause health problems for a heterosexual man having sex with an HPV-infected woman. If a partner has HPV, it does not necessarily mean they have had sex with someone else recently. The virus can lay dormant in the body for years without causing noticeable symptoms.

How to diagnose genital warts in men? To diagnose genital warts in men, the doctor will visually check a man's genital area to see if warts are present. Some doctors will apply a vinegar solution to help identify warts that aren't raised and visible. But the test is not foolproof. Sometimes normal skin is mistakenly identified as a wart.

There is no routine test for men to check for high-risk HPV strains that can cause cancer. However, some doctors are urging anal Pap tests for gay and bisexual men, who are at higher risk of anal cancer caused by HPV. In an anal Pap test, the doctor collects cells from the anus, and then has them checked for abnormalities in a lab.

HPV in men may clear from the body more easily than in women. Women, in general, often clear the virus in two years or less. The HPV vaccine Gardasil, approved for use in women in 2006, is not yet approved for men. Studies are still being done to determine if the vaccine works in males. Eventually, public health experts say, boys and men may be vaccinated.

Anal cancer can be treated with radiation, chemotherapy, and surgery. The specific treatments depend on the stage of cancer -- how big the tumor is and how far the cancer has spread. Early treatment of warts is discouraged by some doctors because genital warts can go away on their own. It can also take time for all warts to appear.

So a person who treats warts as soon as they appear may need another treatment later on. There is no treatment for HPV infection in men when no symptoms are present. Instead, doctors treat the health problems that are caused by the HPV virus. When genital warts appear, a variety of treatments can be used.

The patient can apply prescription creams at home. Or a doctor can surgically remove or freeze off the warts. However, the patient is subject to a painful surgical intervention which results in skin damage/scarring along with the probability the warts will return. Vaccine can stop the HPV virus from infecting the system but is not useful at all for those already affected with warts.

As the antiviral properties of AntiWarts-Rx have the demonstrated ability to penetrate all layers of the skin and enter the blood stream via topical application, they have received considerable attention. Some of the most impressive results consistently achieved with medicinal plants are in the elimination of warts.

When treating warts, application of AntiWarts-Rx hits the infection hard and fast utilizing the powerful forces of its naturally occurring monoterpenes. These micro particles provide the most rapid absorption; they enter cell membranes with incredible swiftness and have a direct antiviral effect against warts.

Viruses exhibit rapid rates of mutation which can make immunity difficult to sustain. Once a cell is infected it is difficult to selectively inhibit the virus without harming the host cell. As a result, much interest has focused on plants as strong allies in restoring immune strength and inhibiting the spread of viral diseases. To learn more, please go to http://www.naturespharma.org.

 

bcured - About the Author:

staff of Nature Power Company, which is a network company dedicated to promoting customers\' websites and developing softwares. You can go to the following websites to learn more about our natural organic products. http://www.bcured.net  http://www.naturespharma.org

Source:  http://www.articlesbase.com/medicine-articles/treatments-for-hpv-infection-in-men-1809978.html

Anal Genital Warts

Anal gential wart (also known as venereal gential wart, anal gential warts and condylomata acuminata) are external symptoms of infection by the human papilloma virus (HPV). hpv is a family of viruses with more than 100 strains, the symptoms of which include anal gential warts, genital anal warts, common warts on hands, and plantar warts on feet.

The American Social Health Association reports the number of Americans with at least one form of sexually transmitted hpv at more than 20 million, with approximately 5.5 million new cases every year, making it the most prevalent and rapidly spreading sexually transmitted disease in the country.

Anal Gential Warts symptoms

It is important to note that many individuals infected with HPV do not have outward signs, and may not know they are infected. Results from a study conducted by the National Institute for Allergies and Infectious Diseases indicate that as many as 50% of women infected with HPV do not show outward symptoms and are unaware that they are infected. This is a considerable factor in the rapid spread of the virus.

When anal gential warts do appear, they can range in size from very tiny bumps to large cauliflower-shaped growths. anal warts which occur outside the rectum are called perianal, those which occur inside the rectum are called intra-anal and effect the lower inch or two of the rectum.

While pain is generally not associated with anal gential warts, occasionally minor bleeding will result from anal sex or bowel movements. Left untreated, anal warts may result in bowel obstruction.

Gential anal warts are highly contagious and transmission most often results from direct contact, usually sexual in nature, with an infected individual. It is estimated that two thirds of people having sexual contact with infected individuals will develop genital or anal warts within three months.

While common gential warts that appear on the hands and feet are forms of HPV, they are not the same strain of HPV virus that causes anal warts. Contact with an individual inter-mittently affected by common warts will not result in venereal gential wart transmission, unless the individual also carries a venereal wart strain of the HPV virus.

Detection and Diagnosis of Anal Warts

Because HPV is not a systemic infection, that is, it exists only in the skin cells, there is no blood test to detect it. Medical personnel will typically identify an anal wart infection by visually inspecting the suspected area, sometimes with a magnifying glass, to verify the presence of warts. Sometimes vinegar is applied to the skin to cause infected tissues to turn white, and render them more easily perceptible.

Anal Wart Treatment

Gential anal warts are the outward symptoms of a viral infection which may persist indefinitely in the tissues around the affected area. Treatments are intended to remove the warts so as to reduce the possibility of spreading the virus to others, as well as to eliminate any physical or psychological discomfort associated with anal warts. Removal of warts, however, is not necessarily a cure. As long as the virus is present, anal warts may recur and require additional treatment.

Various treatments are currently recommended by physicians to remove anal warts. Anal wart treatment s include, but are not limited to, topical chemical solutions, topical anti-viral solutions, immunotherapy, cryotherapy (using liquid nitrogen), surgical removal, and electrosurgery.

Coping with anal warts

Most people are very upset to discover they have contracted a sexually transmitted form of HPV. Gathering as much information about the virus as possible and seeking out support groups can be very helpful in coming to terms with the situation and moving for-wardto a happy, healthy life.

Protection against anal warts

Abstaining from sex with individuals infected with warts or HPV is the best way to avoid contracting the virus or passing it on to a sexual partner. Obviously this is not always practical advice. Since the infection is not always apparent, and because committed partners may decide the risk of passing HPV is outweighed by the benefits of initiating a sexual relationship, use of a condom or dental dam (female sexual barrier device) is recommended for any and all sexual activity. This precaution does not ensure safety from infection, as the virus may be present in skin surrounding the genitals, and therefore notcovered by the barrier.

Note: This information is not intended as a substitute for medical advice. If you suspect you have venereal warts or anal warts, consult a physician.

gabriele valenti - About the Author:

Eric Johnson writes about HPV and Warts Treatments and Genital Warts and warts Treatments

Source:  http://www.articlesbase.com/diseases-and-conditions-articles/anal-genital-warts-187754.html